Filing Details
- Accession Number:
- 0001104659-15-016814
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-04 20:16:17
- Reporting Period:
- 2015-03-01
- Filing Date:
- 2015-03-04
- Accepted Time:
- 2015-03-04 20:16:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100412 | Array Biopharma Inc | ARRY | Pharmaceutical Preparations (2834) | 841460811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1590157 | R Andrews Robbins | C/O Array Biopharma Inc. 3200 Walnut Street Boulder CO 80301 | Svp, Commercial Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-03-01 | 32,069 | $7.96 | 32,069 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-03-01 | 10,493 | $7.96 | 21,576 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2015-03-02 | 21,576 | $8.25 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2015-03-01 | 32,069 | $0.00 | 32,069 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 32,069 | 2018-08-18 | No | 4 | M | Direct |
Footnotes
- Shares issued upon settlement of Restricted Stock Units ("RSUs") granted by the Issuer on August 18, 2014 as a result of the vesting of one half of such RSU's.
- Represents shares withheld to satisfy tax withholding obligations of the reporting person.
- The price reflects the weighted average price for the 40,000 shares which were sold in the range of $8.22 - $8.28. Full information about the number of shares sold at each price is available upon request.
- RSU's were awarded to the reporting person for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma Inc. common stock. RSU's representing 32,069 shares of common stock vested on March 1, 2015 and 32,069 shares remain unvested and subject to achievement of a second milestone relating to the return of rights to binimetinib to the issuer on or prior to the fourth anniversary of the grant date, in each case subject to continued service with the Company as of each vesting date.
Billionaire Hedge Funds
